GlassScriptPhysician profile
Matthew A Hubbard
NPI 1700100286
$2,769.05
in general payments reported to CMS, 2019-2025
17 companies · $199 in 2025
The $199 reported for 2025 was less than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.12 · 2020: $76.00 · 2021: $467 · 2022: $1,407 · 2023: $312 · 2024: $226 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $737.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $736.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,408.27 | 2021-2024 | Xpress Loprofile |
| Glaxosmithkline, LLC. | $475.60 | 2021-2025 | Nucala, Trelegy Ellipta |
| Genzyme Corporation | $171.93 | 2019-2021 | |
| Musculoskeletal Transplant Foundation INC. | $140.96 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $130.50 | 2021-2024 | Dupixent |
| Inspire Medical Systems, INC. | $110.77 | 2023 | Inspire |
| Optinose US, INC. | $85.94 | 2022 | |
| Novartis Pharmaceuticals Corporation | $52.46 | 2019-2020 | |
| Pfizer INC. | $49.40 | 2020-2021 | |
| Uswm, LLC | $28.00 | 2021 | |
| Cochlear Americas | $21.22 | 2025 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha, Osia Osi300 Implant |
| Integra Lifesciences Corporation | $18.55 | 2024 | Acclarent Aera |
| Medtronic, INC. | $16.77 | 2025 | Stealthstation S8 Platform |
| Intersect Ent, INC. | $16.47 | 2022 | |
| Microline Surgical INC | $15.70 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.22 | 2021 | |
| Ambu INC. | $12.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Hubbard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.